Pitt will be open for the fall. All activities of the University—teaching, housing and residence life, student activities, food services, research, athletics and more—will still occur, but according to the requirements in our infection prevention and control program. We will modify some of our activities to ensure that they remain safe and consistent with our commitment to managing risks related to the novel coronavirus.

The University remains committed to providing the finest educational experience, with the health, safety and well-being of our campus community guiding every decision we make. The Office of the Senior Vice Chancellor for Research has compiled preliminary interim guidance and resources for a Research Restart at Pitt. Please visit that page often for the latest information.

Research teams at the University of Pittsburgh and UPMC have mobilized to plan and implement clinical trials and clinical research studies related to COVID-19. Given the rapidity of the spread of disease, timely and efficient implementation of studies are critical to their success.

To support and facilitate these studies, the Clinical and Translational Science Institute (CTSI) is mobilizing to help coordinate resources, expertise, research tools and lab capabilities. CTSI will catalogue every Pitt or UPMC COVID-19-related research protocol involving human subjects and/or associated biosamples, electronic health records and other data. This will enable Pitt and UPMC to:

  • Identify collaborative opportunities among study teams
  • Coordinate with HRPO to streamline regulatory submissions
  • Assess researchers’ needs
  • Provide research tools (e.g., electronic consents)
  • Leverage expertise (e.g., study design)
  • Link to institutional resources (e.g., biobanking, Health Record Research Request (R3))
  • Harmonize data elements across studies
  • Help provide integration with national and international research efforts

All principal investigators planning or conducting COVID-19-related studies should submit a brief description of their proposal. Funding opportunities are available from multiple sources. Please send requests for additional information to covid19research@pitt.edu.

Updated March 23

Pitt will be open for the fall. The current planning effort supports all activities of the University, including teaching, housing and residence life, student activities, food services, research, athletics and more. These activities will still occur, but according to the new requirements outlined in our infection prevention and control program. As a result, we will need to modify some of our activities to ensure that they remain safe and consistent with our commitment to manage risks related to the novel coronavirus.

Updated June 8

View More

At the recommendation of the Department of State, and considering the current travel restrictions, the Office of the Provost has suspended all new J-1 scholar programs until further notice and at least until August 1, 2020. Department administrators should coordinate with OIS in order to extend or cancel currently scheduled scholars.

The April 22, 2020, presidential proclamation will have no effect on current Pitt international employees and scholars. It suspends, for the next 60 days, the granting of green cards only to those individuals currently outside the U.S. Those within the U.S. can continue to file nonimmigrant extensions (H-1Bs, TN, etc.), and green card applications will continue to be adjudicated for those who currently reside within the U.S.

For additional information, OIS has posted a detailed summary of the proclamation.

Regarding H-1B and other visa holders, the April 22 proclamation included an order directing the Departments of Labor and Homeland Security to review nonimmigrant programs and recommend other appropriate measures to stimulate the U.S. economy and ensure the prioritization, hiring and employment of United States workers. OIS will continue to monitor the situation and provide additional updates as necessary. 

Updated April 22

Current CDC and Pitt requirements indicate that work with or culturing of the the virus that causes COVID-19 (SARS-CoV-2) must be performed at Biosafety Level 3. A CDC Import Permit for SARS-CoV-2 is required to obtain virus isolates and/or patient samples from cases under investigation. The import permit process is now electronic through the CDC. At present, SARS-CoV-2 is not a select agent; however, it should be noted that Pitt is NOT currently registered for work with SARS-CoV-1, which is a select agent. Any investigator wishing to initiate research using SARS-CoV-1, MERS-CoV or SARS-CoV-2 must inform the RO/ARO in Environmental Health and Safety at 412-624-9505.

Updated March 23

Updated March 23

Where can I find information on working, teaching or learning remotely?

In support of Provost and Senior Vice Chancellor Ann E. Cudd’s message for faculty on the change in operations, along with Vice Chancellor of Human Resources David DeJong’s message to staff, the following resources are available to help students, faculty and staff with tools and guidance for remote working, learning and teaching.

The University Center for Teaching and Learning hosts information and resources to ensure course continuity. Instructors can find information on course delivery options, educational technology tools, a preparedness checklist, and support and guidance.

Pitt Information Technology provides a wealth of resources for remote work.

Updated June 19

View More

What is Zoombombing and how do I prevent it?

The rapid adoption of Zoom video conferencing by universities across the country has helped facilitate remote teaching and work—including across all Pitt campuses. Unfortunately, this most useful tool has also become the target of “Zoombombing” by bad actors, a practice in which uninvited attendees disrupt a meeting by sharing inappropriate or offensive material.

Updated June 19

View More